je.st
news
Cardiome Pharma Corp (CRME) Receives "Buy" Rating from Canaccord Genuity
2016-03-13 15:32:23| Biotech - Topix.net
's stock had its "buy" rating reaffirmed by investment analysts at Canaccord Genuity in a research report issued on Sunday, AnalystRatings.NET reports. They presently have a $10.00 target price on the biopharmaceutical company's stock.
Tags: buy
rating
corp
receives
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||